212 related articles for article (PubMed ID: 14561696)
21. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
22. Double target for tumor mass destruction.
Saharinen P; Alitalo K
J Clin Invest; 2003 May; 111(9):1277-80. PubMed ID: 12727916
[No Abstract] [Full Text] [Related]
23. Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells.
Bondjers C; Kalén M; Hellström M; Scheidl SJ; Abramsson A; Renner O; Lindahl P; Cho H; Kehrl J; Betsholtz C
Am J Pathol; 2003 Mar; 162(3):721-9. PubMed ID: 12598306
[TBL] [Abstract][Full Text] [Related]
24. [Basic science of angiogenesis and its progress in clinical application].
Takakura N
Rinsho Ketsueki; 2008 Oct; 49(10):1451-9. PubMed ID: 18833929
[No Abstract] [Full Text] [Related]
25. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
26. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
27. Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis.
Huang J; Soffer SZ; Kim ES; McCrudden KW; Huang J; New T; Manley CA; Middlesworth W; O'Toole K; Yamashiro DJ; Kandel JJ
Mol Cancer Res; 2004 Jan; 2(1):36-42. PubMed ID: 14757844
[TBL] [Abstract][Full Text] [Related]
28. Pericytes in the microvasculature.
Hirschi KK; D'Amore PA
Cardiovasc Res; 1996 Oct; 32(4):687-98. PubMed ID: 8915187
[TBL] [Abstract][Full Text] [Related]
29. Involvement of vessels and PDGFB in muscle splitting during chick limb development.
Tozer S; Bonnin MA; Relaix F; Di Savino S; García-Villalba P; Coumailleau P; Duprez D
Development; 2007 Jul; 134(14):2579-91. PubMed ID: 17553906
[TBL] [Abstract][Full Text] [Related]
30. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
[TBL] [Abstract][Full Text] [Related]
31. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
32. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma.
Lu C; Kamat AA; Lin YG; Merritt WM; Landen CN; Kim TJ; Spannuth W; Arumugam T; Han LY; Jennings NB; Logsdon C; Jaffe RB; Coleman RL; Sood AK
Clin Cancer Res; 2007 Jul; 13(14):4209-17. PubMed ID: 17634550
[TBL] [Abstract][Full Text] [Related]
33. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling.
Lamy S; Beaulieu E; Labbé D; Bédard V; Moghrabi A; Barrette S; Gingras D; Béliveau R
Carcinogenesis; 2008 May; 29(5):1033-41. PubMed ID: 18339683
[TBL] [Abstract][Full Text] [Related]
34. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA
Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450
[TBL] [Abstract][Full Text] [Related]
35. The immature endothelial cell in new vessel formation following surgical injury in rat brain.
Frontczak-Baniewicz M; Gordon-Krajcer W; Walski M
Neuro Endocrinol Lett; 2006 Aug; 27(4):539-46. PubMed ID: 16891988
[TBL] [Abstract][Full Text] [Related]
36. PKC/MAPK signaling suppression by retinal pericyte conditioned medium prevents retinal endothelial cell proliferation.
Kondo T; Hosoya K; Hori S; Tomi M; Ohtsuki S; Terasaki T
J Cell Physiol; 2005 May; 203(2):378-86. PubMed ID: 15499572
[TBL] [Abstract][Full Text] [Related]
37. Endothelial-pericyte interactions in angiogenesis.
Gerhardt H; Betsholtz C
Cell Tissue Res; 2003 Oct; 314(1):15-23. PubMed ID: 12883993
[TBL] [Abstract][Full Text] [Related]
38. Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
Davis DW; Takamori R; Raut CP; Xiong HQ; Herbst RS; Stadler WM; Heymach JV; Demetri GD; Rashid A; Shen Y; Wen S; Abbruzzese JL; McConkey DJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):678-89. PubMed ID: 15701856
[TBL] [Abstract][Full Text] [Related]
39. PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta.
Ohlsson R; Falck P; Hellström M; Lindahl P; Boström H; Franklin G; Ahrlund-Richter L; Pollard J; Soriano P; Betsholtz C
Dev Biol; 1999 Aug; 212(1):124-36. PubMed ID: 10419690
[TBL] [Abstract][Full Text] [Related]
40. Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.
Sennino B; Falcón BL; McCauley D; Le T; McCauley T; Kurz JC; Haskell A; Epstein DM; McDonald DM
Cancer Res; 2007 Aug; 67(15):7358-67. PubMed ID: 17671206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
